Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Sendai virus recombinant vaccine expressing hPIV-3 HN or F elicits protective immunity and combines with a second recombinant to prevent hPIV-1, hPIV-3 and RSV infections.

Zhan X, Slobod KS, Krishnamurthy S, Luque LE, Takimoto T, Jones B, Surman S, Russell CJ, Portner A, Hurwitz JL.

Vaccine. 2008 Jun 25;26(27-28):3480-8. doi: 10.1016/j.vaccine.2008.04.022. Epub 2008 May 1.

2.

Recombinant Sendai virus as a novel vaccine candidate for respiratory syncytial virus.

Takimoto T, Hurwitz JL, Zhan X, Krishnamurthy S, Prouser C, Brown B, Coleclough C, Boyd K, Scroggs RA, Portner A, Slobod KS.

Viral Immunol. 2005;18(2):255-66. Review.

PMID:
16035938
3.

Sendai virus as a backbone for vaccines against RSV and other human paramyxoviruses.

Russell CJ, Hurwitz JL.

Expert Rev Vaccines. 2016;15(2):189-200. doi: 10.1586/14760584.2016.1114418. Epub 2015 Dec 9. Review.

4.

Strategic priorities for respiratory syncytial virus (RSV) vaccine development.

Anderson LJ, Dormitzer PR, Nokes DJ, Rappuoli R, Roca A, Graham BS.

Vaccine. 2013 Apr 18;31 Suppl 2:B209-15. doi: 10.1016/j.vaccine.2012.11.106. Review.

5.

Progress in the development of human parainfluenza virus vaccines.

Schmidt AC, Schaap-Nutt A, Bartlett EJ, Schomacker H, Boonyaratanakornkit J, Karron RA, Collins PL.

Expert Rev Respir Med. 2011 Aug;5(4):515-26. doi: 10.1586/ers.11.32. Review.

6.

Recombinant measles AIK-C vaccine strain expressing heterologous virus antigens.

Nakayama T, Sawada A, Yamaji Y, Ito T.

Vaccine. 2016 Jan 4;34(2):292-5. doi: 10.1016/j.vaccine.2015.10.127. Epub 2015 Nov 10. Review.

PMID:
26562316
7.

Induction of protective effector immunity to prevent pathogenesis caused by the respiratory syncytial virus. Implications on therapy and vaccine design.

Espinoza JA, Bueno SM, Riedel CA, Kalergis AM.

Immunology. 2014 Sep;143(1):1-12. doi: 10.1111/imm.12313. Review.

8.

Parainfluenza viruses.

Henrickson KJ.

Clin Microbiol Rev. 2003 Apr;16(2):242-64. Review.

9.

[Potential neurocognitive consequences of infection by human respiratory syncytial virus].

Flores JC, Bohmwald K, Espinoza J, Jara C, Peña M, Hoyos-Bachiloglu R, Iturriaga C, Kalergis AM, Borzutzky A.

Rev Chilena Infectol. 2016 Oct;33(5):537-542. doi: 10.4067/S0716-10182016000500008. Review. Spanish.

Supplemental Content

Support Center